Pembrolizumab-induced acute thrombosis: A case report

RATIONALE: Acute thrombosis has not been reported in the literature so far in lung cancer patients as an immune-related adverse event (irAE) associated with PD-1 pathway inhibitors. PATIENTS CONCERNS: Here, we for the first time present two NSCLC (non-small cell lung cancer) patients suffering from...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunimasa, Kei, Nishino, Kazumi, Kimura, Madoka, Inoue, Takako, Tamiya, Motohiro, Kumagai, Toru, Imamura, Fumio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976311/
https://www.ncbi.nlm.nih.gov/pubmed/29768369
http://dx.doi.org/10.1097/MD.0000000000010772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976311/
https://www.ncbi.nlm.nih.gov/pubmed/29768369
http://dx.doi.org/10.1097/MD.0000000000010772

Ejemplares similares